Free-text search
Content Types
-
Per-Ola Carlsson honoured for diabetes research
Professor Per-Ola Carlsson, of Uppsala University and Akademiska sjukhuset, has been awarded the 2026 Kerstin Brismar Award, which includes a research grant of SEK 500,000.
-
Decision on rival CAR-T therapies: Yes to Yescarta, no to Breyanzi
Sweden’s Council for New Therapies (NT-rådet) has assessed two CAR-T therapies for follicular lymphoma, reaching very different conclusions.
-
Swedish medtech firm misses out on EU funding – files for bankruptcy
The Lund-based medical technology company NanoEcho has filed for bankruptcy following financial difficulties.
-
Labour drug shortage in Sweden could be fixed by looking towards Denmark
Important labour ward drug is being discontinued in Sweden, but Denmark has already found a solution.
-
Abbott gets FDA nod for updated heart failure system
Abbott has received approval from the U.S. Food and Drug Administration (FDA) for updates to its implantable heart monitoring system.
-
Viatris to buy Pacira for $1.65 billion
Viatris is acquiring Pacira BioSciences for $1.65 billion, strengthening its portfolio with two high-margin, non-opioid pain treatments.
-
Pfizer wins new FDA approval for Tukysa in breast cancer
Pfizer is strengthening its position in HER2-positive breast cancer. The FDA has approved Tukysa as a first-line maintenance treatment after a phase III trial s...
-
Danish Care call out Danish government: “The industry is ready”
The Danish sector for assistive devices and welfare technology is growing, but the improvement is uneven. Industry association calls for political action on the matter.
-
Roche's Tecentriq gets FDA nod after strong colon cancer data
A combination of Tecentriq and chemotherapy cut the risk of recurrence or death by half in patients with stage III colon cancer and dMMR tumours. The results ha...
-
Gothenburg researcher aims to launch CAR-T trial for childhood brain tumours
A year ago, Lars Karlsson was named Childhood Cancer Researcher of the Year for his work in the US on CAR-T therapy for children with the aggressive brain tumou...
-
ZEISS Innovation Summit 2026 brings together international experts from industry and research
Event in Berlin to focus on artificial intelligence, automation, and trends in manufacturing and life sciences.
-
CCLs: The Bridge Between Research and Practice
At Aurevia, we have experienced Clinical Country Liaisons (CCLs), a role that shares many characteristics with Medical Science Liaisons (MSLs), including a stro...
-
European biopharma leaders are optimistic on funding issue, but it keeps them up at night
The European biotech leaders see an increase in the acces to capital over the next year, but there's still worries on the matter.
-
Björn Arvidsson: “We skip the most important step after research”
In Sweden, we are proud of our research – and rightly so. We invest substantial resources and have internationally recognised strengths in life science. But whe...
-
Nobel laureate’s CRISPR biotech shuts down as funding runs out
Caribou Biosciences was one of the early companies to embrace CRISPR gene-editing technology. Now, the biotech is being forced to halt development of its cancer...
-
How GLP-1 drugs are changing what we buy at the supermarket
In both Sweden and Denmark, grocery industry organisations are predicting billion-krona sales losses as the use of weight-loss drugs increases. So far, however,...
-
EU Discusses Suspected Pneumonic Plague Case in Russia
EU member states discussed the suspected case of pneumonic plague in Russia after the issue was added Wednesday to the agenda of the Health Security Committee. ...
-
WHO puts lifestyle changes before weight-loss drugs for children
The World Health Organization (WHO) has published its first global guidelines for tackling obesity among children and adolescents. The recommendations include d...
-
Mirror-image molecule discoveries win Nobel Prize in Chemistry
The 2026 Nobel Prize in Chemistry is awarded to French chemist Henri B. Kagan and Japanese chemist Kenso Soai for discoveries that explain how chemical reaction...
-
Forbion raises €2.3bn in record life science fundraising
Dutch life science investor Forbion has raised 2.3 billion euros – capital that could provide funding for around 30 biotech companies.
-
Natural Cycles sharpens Nordic focus with new regional chief
After nearly a decade at Natural Cycles, Sofie Askervall has stepped into the newly created role of Head of Nordics. “Right now, we are looking closely at Norway,” she says.
-
Stryker CEO steps down – company veteran takes over
After more than 15 years at Stryker, Kevin Lobo will step down as CEO at the end of the year. He will be succeeded by Chief Operating Officer Spencer Stiles, wh...
-
Medivir’s second act: three drugs to enter Phase 2
As recently as last autumn, the situation was critical, with cash reserves dwindling and the share price falling. Today, Medivir is well funded, its ownership s...
-
AstraZeneca opens $1bn R&D centre in US
AstraZeneca has now opened its new research and development centre in Cambridge, Massachusetts – an investment of nearly 1 billion dollars.
BREAKING